about
Zika Virus: Where Is the Treatment?Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog TherapyDengue: Moving from Current Standard of Care to State-of-the-Art TreatmentJapanese Surveillance Systems and Treatment for Influenza.Treatment options in Invasive Aspergillosis.Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning TravelersClinical Treatment Options Infectious Diseases: Update on PrEP Implementation, Adherence, and Advances in DeliveryOutcome Assessments in Clinical Trials of Cryptococcal Meningitis: Considerations on Use of Early Fungicidal Activity as a Potential Surrogate Endpoint for All-Cause Mortality.Bone Loss in HIV Infection.Treatment of Non-Tuberculous Mycobacterial Lung Disease.Discovering Drugs for the Treatment of Ebola Virus.Surveillance and Prevention of Surgical Site Infections in Breast Oncologic Surgery with Immediate Reconstruction.Cytomegalovirus Treatment.Antimicrobial Stewardship Programs: Appropriate Measures and Metrics to Study their Impact.Retreatment Options Following HCV Direct Acting Antiviral Failure.Nontuberculous Mycobacteria in Cystic Fibrosis.Hypogonadism in the HIV-Infected Man.Treatment of Hepatitis C Virus (HCV) Genotype 1 Disease.Current Treatment Options for HIV Elite Controllers: a ReviewSolid Organ Transplantation for HIV-Infected IndividualsTreatment of Latent Tuberculosis InfectionAerosol-Transmitted Infections—a New Consideration for Public Health and Infection Control TeamsAntimicrobial Stewardship Strategies in Nursing Homes: Urinary Tract InfectionsWhat to do Next? Second-line Antiretroviral TherapyMetabolic Syndrome in HIV/HCV Co-infected PatientsBuilding a Hepatitis C Clinical Program: Strategies to Optimize OutcomesUsing Artificial Intelligence in Infection PreventionEnvironmental Cleaning in Resource-Limited SettingsControlling infectious disease outbreaks in low-income and middle-income countriesTransmission and Control of Respiratory Viral Infections in the Healthcare SettingTherapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection: How Close Are We?The Role of Clinical Virology Laboratory and the Clinical Virology Laboratorian in Ensuring Effective Surveillance for Influenza and Other Respiratory Viruses: Points to Consider and Pitfalls to AvoidSustaining Hospital Readiness for EbolaProcess Development for the Care of the Person Under Investigation for Ebola Virus Disease: a Collaboration of Biocontainment Unit and Emergency Medicine PersonnelA Brief History of BiocontainmentRole of Human Factors Engineering in Infection Prevention: Gaps and OpportunitiesInfections and outbreaks of nontuberculous mycobacteria in hospital settingsTreatment of Chagas Disease in the United StatesSeasonal Human Influenza: Treatment OptionsInfluenza Vaccination and Healthcare Personnel Compliance
P1433
Q25707110-0FBE5866-6686-4930-B70A-2C82606D47DEQ26740161-854FCCB6-2259-40F1-A00B-0A7D2173BF17Q27010609-1F2EAD08-E43D-4E15-ACC2-F82F1DBD75E3Q30239895-CFB28E27-3813-4200-8F5F-7064556E5D8BQ34357504-CCC5CF57-6BF8-4323-85D6-FD76EEF2AFAEQ35180338-85D99F09-EB56-4539-A35A-84640196A998Q35541521-C965F29E-B825-41D4-B97E-871D1A7076BAQ35984938-75B5CC24-9B59-4939-85C4-B3C05C136538Q38835028-40B2BE10-43FE-4F7A-8907-015D1C7DED0DQ39321216-7B5889D9-C6ED-4F4B-BABA-078A6EBCB1E9Q40039706-295A904E-AB32-4398-9075-71B76FE4E701Q41993238-94E3599F-22EF-46FC-B7FC-ABFF6FD9C9B2Q42554715-4C20CA34-26DE-4500-BC38-0495A0FB4692Q42554730-824C45B9-2F0D-4874-9401-16389946B537Q47306709-2F1CBA9D-643C-4F52-BFAF-BCE1DCBC4EDEQ52768051-B9F9981B-0118-4DC8-AAD4-015EFAF5ECC7Q54101646-04BD4263-A9F1-4EF6-8BAC-89274340708EQ55218109-0B8CA0A0-1E91-4027-90B5-529B402E2DF2Q57825309-3DCF8244-3EB2-462C-B3DD-0A83F2DE99DFQ59357554-4BE5B6AF-60B1-4C1A-92B5-F52459EA35DAQ59522441-11C61B7C-5E8E-4591-85C9-936D7078B38EQ59896721-F621DEB5-4C87-42C7-969F-77F305BA82F1Q61850031-7333162B-5BC6-4498-B0C3-10230E537E8EQ61952039-CA85924C-5695-4B89-9BEA-9BDD3FA4C995Q89584749-66E2D8D1-A626-44DC-92A8-246A65442C6CQ90323211-509C0AB0-DC17-4152-A523-9068D11F3E00Q90697314-9DC15173-8B99-4FB0-AEFA-351495BF39C3Q90745110-39B869B4-FC22-4F36-B6C6-CF12BCC702DEQ90745115-0FB39D2E-22DD-4308-95DE-5EA9967EA1CEQ90745119-3C6646C5-0A1B-4436-9C67-0A2AAD5E944EQ90745132-CF9DE9D5-3035-4EA6-909F-F9A0057F779CQ90745138-5C42A757-438E-46E6-856E-7E468A2BD568Q90745144-68BDF61F-4440-4E9E-9621-94DC567490B8Q90745149-E7586E04-F0A1-4615-91EC-A04288E6F400Q90745155-999587D5-6284-4080-BB3C-F016A75E69A3Q90745162-8B2353B5-B4A6-49DE-8B65-92FC81EB6D24Q91131530-317FBFED-38C3-49B2-85E6-D5B7FAB7BA1FQ91472892-D72F6226-5E22-4470-86AF-3D7A6BC34B87Q91910138-8BBB453C-D6E9-4647-9A2D-956B8DC25ECDQ95261243-E2082DAF-20B5-488C-B7BE-DD53233466A6
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Springer Science+Business Media
@nl
wissenschaftliche Fachzeitschrift
@de
name
Current treatment options in infectious diseases
@ast
Current treatment options in infectious diseases
@en
Current treatment options in infectious diseases
@es
Current treatment options in infectious diseases
@it
Current treatment options in infectious diseases
@nl
type
label
Current treatment options in infectious diseases
@ast
Current treatment options in infectious diseases
@en
Current treatment options in infectious diseases
@es
Current treatment options in infectious diseases
@it
Current treatment options in infectious diseases
@nl
prefLabel
Current treatment options in infectious diseases
@ast
Current treatment options in infectious diseases
@en
Current treatment options in infectious diseases
@es
Current treatment options in infectious diseases
@it
Current treatment options in infectious diseases
@nl